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Abstract  
Background: There is considerable worldwide rising incidence of slow growing Papillary Thyroid Microcarcinoma 
(PTMC) due to increasing availability of modern imaging tools. Cervical lymph node metastasis still remains the most 
frequent site of its metastasis. Here we present a rare case of PMC resulting in Horner’s syndrome, which to our 
knowledge is the first case in the history of known medical literature. 
Case Report: A 32 years old male presented with right posterior triangle cervical lymphadenopathy, drooping of right 
eyelid and anhydrosis for last 3 years. Biopsy of the swelling revealed metastatic papillary thyroid carcinoma. US neck 
and computerized tomography showed a mass in the right suprclavicular region closely adherent to the common carotid 
and the stellate ganglion area without any significant pathology within thyroid and the lung. The patient underwent total 
thyroidectomy with type II block neck dissection. The specimen revealed microscopic foci of papillary thyroid carcinoma 
involving right lobe, largest focus measuring 0.2cm. Cervical lymph nodes of level II were negative for cancer metastasis 
however level III, IV and V were positive for metastasis. Patient underwent I131 radio-ablation postoperatively and is 
disease free since operation.  
Conclusion: Here we demonstrate a novel presentation of the PTMC inform of Horner’s syndrome and give brief review 
of literature regarding presentation of PTMC.  
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Introduction 
Papillary thyroid microcarcinoma (PTMC) is defined as a small tumor that measures less than or equal 
to 1cm in diameter [1]. It is often undetected on clinical examination and found incidentally after 
thyroidectomy performed for other reasons or during a thyroid ultrasound exploration [1, 2]. PTMC 
can either be incidentally detected or remains occult. The average prevalence of PTMC is around 10% 
with a wide range 2.0–35.6% [3-7]. The clinical behavior of these tumors tends to be indolent with an 
excellent prognosis. Most of the series have reported a very low mortality rate between 0% and 0.4% 
[8-14]. Regardless of form of presentation PTMC, multicentricity, bilaterality, and minor 
extrathyroidal invasion are found with the same frequency as clinical PTCs, while lymph node 
metastases and distal metastases occur with lower frequency [8-13]. The optimal management of 
PTMC patients can range from observation without surgery based on a recent clinical trial carried out 
by Japanese authors [10-15] to total thyroidectomy with neck dissection followed by radioiodine 
treatment depending on the presence of aggressive characteristics [16,17].  
Here we present an interesting case of occult PTMC, which presented with right sided cervical 
lymphadenopathy and Horner’s Syndrome. 
Case Report 
A 32-year-old male patient came to our department with complaints of right posterior triangle mass of 
the neck, drooping of right eyelid and anhydrosis of ipsilateral half of face for last 3 years. There was 
no significant family history of thyroid cancer.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 A. Preoperative markings of the neck showing mass and involved lymph nodes in the patient. B. shows 
the right sides ptosis and C. shows the right sided papillary constriction as opposed to left.  
 
Examination of neck revealed a swelling located on right lower aspect of neck, which was hard, 
immobile with irregular margins. Multiple matted and discrete hard-enlarged lymph nodes were also 
found. On ophthalmic examination there was mild asymmetry of pupillary diameter, right being less 
than left, decreased palpebral aperture and negative starch test, all suggesting the diagnosis of 
Horner’s Syndrome. FNAC of the mass revealed metastatic papillary thyroid carcinoma after which 
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further workup was done.  
Ultrasound and CT scan of chest and neck showed a mass in the right posterior triangle region 
associated with cervical lymphadenopathy of level 3, 4 and 5. Thyroid gland was essentially normal on 
radiological grounds and no evidence of Pancoast tumor was noted (Figure 2).  
 
 
 
 
 
 
 
 
 
Figure 2 shows the mass in the right suprclavicular region associated with cervical lymph node metastasis. 
 
Figure 3 A. shows marking of the mass. B. & C. show right and left side of neck following total thyroidectomy 
and right sided block neck dissection. D shows resected specimen following block neck dissection. Silk thread 
(P) in the right lobe marks the suspicious area for malignancy in the thyroid. 
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Clinical, Cytological and Imaging data collectively supported the possibility of papillary thyroid cancer 
with lymph node metastasis. Total Thyroidectomy with type II block neck dissection was done with 
predictable safety of parathyroids and recurrent laryngeal nervi. Figure 3 shows the resected specimen with 
silk thread marking the suspicious area of right lobe of thyroid. 
Histological analysis (Figure 4) showed multiple microscopic foci of papillary thyroid carcinoma 
involving right lobe, largest focus measuring 0.2cm. Left lobe and Isthmus were normal. 13 level-II lymph 
nodes were negative for metastasis, 4 out of 19 level-III were positive for metastatic carcinoma of thyroid, 
2 out of 6 level-IV were positive for metastatic carcinoma of thyroid  and 1 out of 12 level-V was positive 
for metastatic carcinoma. Resection margins were clear of tumor. Postoperative period remained uneventful 
and patient was radio-ablated with I131. Patient is disease free following 2 year follow up. 
 
 
Figure 4 A. shows the small focus of Papillary Thyroid Microcarcinoma (PTMC) and B. shows metastasis 
within the representative lymph node. 
Discussion 
Papillary Thyroid Microcarcinoma (PTMC), a small papillary thyroid tumor measuring less than 10 mm in 
size, is being increasingly diagnosed due to wider availability of modern diagnostics. Debate over the 
adequate treatment for this condition still remains open [8,14]. Despite smaller tumor size it has high 
incidence of lymph node metastasis ranging up to 50% urging many thyroid surgeons to opt for a very 
aggressive form of surgical treatment i.e total thyroidectomy with or without neck dissection depending on 
involvement of lymph nodes. The surgeons in favor of this aggressive form of treatment quote lower 
recurrence rate, unpredictable oncological behavior of   tumor and better long term survival and this 
strategy seems reasonable in favor of better disease control. Conversely, a large series from the Mayo clinic 
advocates favorable results with relatively conservative approach for such smaller tumors citing a 10 year 
cause-specific mortality of these tumors to be just 1% [13,14]. This approach emphasizes the use of 
conservative surgical approach based on lesser postoperative complication profile related to total 
thyroidectomy, low cause-specific mortality, slow growing nature of the papillary tumors and similar 
survival curves. The later approach has several advantages and there is now developing consensus that 
smaller tumors can be managed adequately with relatively lesser radical approach in form of lobectomy and 
isthmectomy [13,14].  
The problem lies with a smaller percentage of the patients with small tumors which exhibit higher 
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biological aggression and invasiveness. Many factors now have been localized which predict tumor 
aggression and hence favor use of relatively aggressive surgical approach. These factors include tumor size 
more than 5mm, multifocality, RET/PTC, BRAFV600E and TGF Beta 3 mutations and lymph node 
metastasis at the time of presentation [17]. A consensus yet remains to be generated on these lines after a 
detailed research on epidemiological behavior of the smaller papillary tumors.  
Our current case belonged to this high risk group and the patient underwent total thyroidectomy 
considering the dilemma of not knowing where the primary is and secondly the aggressive biological 
behavior of the tumor as evident by massive lymph node involvement. This case highlights the fact that 
small size of the tumor alone is not sufficient information to go for a conservative surgical option and in 
future the genetic analysis of the mutations may be optimal strategy to decide the extent of surgery.  
Second peculiarity of the case relates to the extensive lymph node metastasis in neck region to involve 
the stellate ganglion to cause Horner’s syndrome. Horner’s syndrome manifests as Miosis, hemifacial 
Anhydrosis, Ptosis and Enophthalmos. It is a syndrome caused by lesion of sympathetic chain at three 
different levels; 1st order central sympathetic fibers, 2nd order preganglionic pupillomotor fibers, and 3rd 
order postganglionic fibers. In our patient there was disruption of preganglionic fibers, which remains the 
most common site of lesion. The most common cause of Horner’s syndrome is non-thyroidal malignancy 
including non-thyroidal lesions [18]. To our best knowledge we have not seen any known report in the 
medical literature to document a PTMC causing Horner’s syndrome. Clearly in such cases it remains 
imperative to exclude other cause of the Horner’s syndrome like Pancost’s Tumor which we did in this 
case.  
Future research should focus on segregation of the PTMCs with higher invasive and aggressive potential 
based on genomic or mutational analysis. Till then total thyroidectomy would remain an appropriate 
treatment for even such smaller tumors in favor of better disease free survival and low recurrence rates.  
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